|Bid||8.93 x 1400|
|Ask||8.98 x 4000|
|Day's Range||8.81 - 9.19|
|52 Week Range||3.58 - 12.44|
|Beta (5Y Monthly)||1.23|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 04, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.67|
These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q3 2021.
Dynavax Technologies (NASDAQ: DVAX) stock was down 6.3% as of 11:26 a.m. EDT, while shares of Novavax (NASDAQ: NVAX) and Vaxart (NASDAQ: VXRT) were falling 7.8% and 10.6%, respectively. The declines for the biotech stocks appear to merely be run-of-the-mill volatility on a day when the overall stock market was down. Sales of its Heplisav-B hepatitis B vaccine were negatively impacted by the COVID-19 pandemic.
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...